Picture of Prestige Consumer Healthcare logo

PBH — Prestige Consumer Healthcare News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

Prestige rises after $1.05 billion deal to buy Breathe Right

** Shares of consumer healthcare products maker Prestige Consumer Healthcare PBH.N rise 2% to $61.00

** Co says it will buy the Breathe Right nasal strip brand, used to ease snoring and blocked noses without drugs, from Foundation Consumer Healthcare

** Deal, valued at $1.045 billion, adds a portfolio that made about $200 mln in revenue and about $95 mln in core earnings in 2025, co says

** Breathe Right makes up about two-thirds of the acquired sales - PBH

** Co says it will pay for the deal with cash and borrowing, and expects debt to rise after the acquisition before falling by fiscal 2028

** Says transaction expected to close in the first half of fiscal 2027, subject to approvals

** Shares down 21% in 2025

 (Reporting by Sahil Pandey in Bengaluru)

 ((Sahil.Pandey@thomsonreuters.com))

Recent news on Prestige Consumer Healthcare

See all news